Publication Beamlines Strategic Pillar
(2024). Exit Window for Electron Beam in Isotope Production. Patent Number: IL268283B2.
(2023). CORE/CASING ENGINEERING WITH GAPS (CSVE) OF CATALYST FOR ELECTROCHEMICAL CO2 REDUCTION. Patent Number: PT3791010T.
(2024). Antibodies that bind to a complex containing TNF from the TNF superfamily and a small molecule that is its modulator. Patent Number: IL256099B2.
(2025). ANTI-BCMA ANTIBODIES, BISPECIFIC ANTIGEN-BINDING MOLECULES BINDING BCMA AND CD3 AND THEIR USES. Patent Number: FR23C1012I2.
(2023). Antibodies to tigit. Patent Number: IL298111A.
(2023). ANTI-BCMA ANTIBODIES, BISPECIFIC ANTIGEN BINDING MOLECULES THAT BIND BCMA AND CD3, AND USES THEREOF. Patent Number: CY2023007I2.
(2023). teclistamab. Patent Number: NL301219I2.
(2023). ANTI-BCMA ANTIBODIES, BCMA AND CD3-BINDING BISPECIFIC ANTIGEN-BINDING MOLECULES AND USES THEREOF. Patent Number: FR23C1011I1.
(2023). Anti-bcma antibodies, bispecific antigen binding molecules that bind bcma and cd3, and uses thereof. Patent Number: IL257468B2.
(2025). Anti-bcma antibodies, bispecific antigen binding molecules that bind bcma and cd3, and uses thereof. Patent Number: IL320478A.
(2023). Novel tnf structure for use in therapy. Patent Number: PT3311168T.
(2025). Anti-bcma antibodies, bispecific antigen binding molecules that bind bcma and cd3, and uses thereof. Patent Number: IL298041B2.
코단다람 필라리세티; 에릭 토마스 볼드윈; 고든 디. 파워스; 로사 마리아 페르난데스 카르도소; 리카도 아타르 et al. (2025). Anti-bcma antibodies, bispecific antigen binding molecules that bind bcma and cd3, and uses thereof. Patent Number: KR20250007058A.
코단다람 필라리세티; 에릭 토마스 볼드윈; 고든 디. 파워스; 로사 마리아 페르난데스 카르도소; 리카도 아타르 et al. (2025). Anti-BCMA antibodies, which are bispecific antigen-binding molecules that bind to BCMA and CD3, and uses thereof. Patent Number: KR102890745B1.
수아레즈 조안 세오아네; 폴게이라 주딧 아니도; 조 프란슨; 진-필리프 줄리엔; 스웨타 라만 et al. (2024). Antibodies against lif and uses thereof. Patent Number: KR102716931B1. CMCF-ID Health